Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity

Frontiers in Immunology

Volumn 6, Issue OCT, 2015, Pages

  Huang, Xinfang ^a,b   Dorta Estremera, Stephanie ^b,c   Yao, Yihong ^d   Shen, Nan ^a   Cao, Wei ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Cellular Biomedicine Group   (United States)

Author keywords

Amyloid; Animal models; Autoantibody; Autoimmunity; B cells; Plasmacytoid dendritic cells; Systemic lupus erythematosus; Type I interferon

Indexed keywords

AUTOANTIBODY; DIPHTHERIA TOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR NF E2;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CELL EXPANSION; CELL INFILTRATION; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE COURSE; GENE OVEREXPRESSION; GLOMERULONEPHRITIS; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MICROENVIRONMENT; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84949545124     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00526     Document Type: Article

References (71)

1. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med (2003) 197(6):711-23. doi: 10.1084/jem.20021553
2. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity (2006) 25(3):383-92. doi:10.1016/j.immuni.2006.08.010
3. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol (2008) 8(8):594-606. doi:10.1038/nri2358
4. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol (2004) 5(12):1219-26. doi:10.1038/ni1141
5. Reizis B, Colonna M, Trinchieri G, Barrat F, Gilliet M. Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol (2011) 11(8):558-65. doi:10.1038/nri3027
6. Di Domizio J, Cao W. Fueling autoimmunity: type I interferon in autoimmune diseases. Expert Rev Clin Immunol (2013) 9(3):201-10. doi:10.1586/eci.12.106
7. Ronnblom L, Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus (2008) 17(5):394-9. doi:10.1177/0961203308090020
8. Crow MK. Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr Opin Rheumatol (2014) 26(5):467-74. doi:10.1097/BOR.0000000000000087
9. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, Locksley R, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell (2008) 135(1):37-48. doi:10.1016/j.cell.2008.09.016
10. Schiavoni G. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8[alpha]+ dendritic dells. J Exp Med (2002) 196:1415-25. doi:10.1084/jem.20021263
11. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol (2003) 170(3):1131-5. doi:10.4049/jimmunol.170.3.1131
12. Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, Lin P, et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2010) 107(46):19973-8. doi:10.1073/pnas.1014051107
13. Baccala R, Gonzalez-Quintial R, Blasius AL, Rimann I, Ozato K, Kono DH, et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc Natl Acad Sci U S A (2013) 110(8):2940-5. doi:10.1073/pnas.1222798110
14. Sisirak V, Ganguly D, Lewis KL, Couillault C, Tanaka L, Bolland S, et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med (2014) 211(10):1969-76. doi:10.1084/jem.20132522
15. Rowland SL, Riggs JM, Gilfillan S, Bugatti M, Vermi W, Kolbeck R, et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J Exp Med (2014) 211(10):1977-91. doi:10.1084/jem.20132620
16. Davison LM, Jorgensen TN. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice. Arthritis Rheumatol (2015) 67(4):1012-22. doi:10.1002/art.38989
17. Wang H, Morse H III. IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol Res (2009) 43(1-3):109-17. doi:10.1007/s12026-008-8055-8
18. Aliberti J, Schulz O, Pennington DJ, Tsujimura H, Reis e Sousa CR, Ozato K, et al. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood (2003) 101(1):305-10. doi:10.1182/blood-2002-04-1088
19. Sasawatari S, Okamura T, Kasumi E, Tanaka-Furuyama K, Yanobu-Takanashi R, Shirasawa S, et al. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology (2011) 140(5):1513-25. doi:10.1053/j.gastro.2011.01.041
20. Kobayashi T, Shimabukuro-Demoto S, Yoshida-Sugitani R, Furuyama-Tanaka K, Karyu H, Sugiura Y, et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity (2014) 41(3):375-88. doi:10.1016/j.immuni.2014.08.011
21. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science (2006) 312(5780):1669-72. doi:10.1126/science.1124978
22. Subramanian S, Tus K, Li Q-Z, Wang A, Tian X-H, Zhou J, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A (2006) 103(26):9970-5. doi:10.1073/pnas.0603912103
23. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity (2007) 27(5):801-10. doi:10.1016/j.immuni.2007.09.009
24. Morel L. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol (2010) 6(6):348-57. doi:10.1038/nrrheum.2010.63
25. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, Hildner K, et al. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2010) 107(33):14745-50. doi:10.1073/pnas.1001562107
26. Belle I, Zhuang YE. Proteins in lymphocyte development and lymphoid diseases. In: Reshma T, editor. Current Topics in Developmental Biology, (Vol. 110). Waltham, MA: Academic Press (2014). p. 153-87.
27. Forrest MP, Hill MJ, Quantock AJ, Martin-Rendon E, Blake DJ. The emerging roles of TCF4 in disease and development. Trends Mol Med (2014) 20(6):322-31. doi:10.1016/j.molmed.2014.01.010
28. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity (2010) 33(6):955-66. doi:10.1016/j.immuni.2010.11.020
29. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med (2008) 358(9):929-39. doi:10.1056/NEJMra071297
30. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 6(12):683-92. doi:10.1038/nrrheum.2010.176
31. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 42(1):102-11. doi:10.1007/s12016-011-8293-8
32. Pollard KM, Kono DH. Requirements for innate immune pathways in environmentally induced autoimmunity. BMC Med (2013) 11(1):100. doi:10.1186/1741-7015-11-100
33. Rubin RL. Drug-induced lupus. Toxicology (2005) 209(2):135-47. doi:10.1016/j.tox.2004.12.025
34. Sideras K, Gertz MA. Amyloidosis. Adv Clin Chem (2009) 47:1-44. doi:10.1016/S0065-2423(09)47001-X
35. Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell (2012) 148(6):1188-203. doi:10.1016/j.cell.2012.02.022
36. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature (2003) 426(6968):895-9. doi:10.1038/nature02263
37. Schnabel J. Protein folding: the dark side of proteins. Nature (2010) 464(7290):828-9. doi:10.1038/464828a
38. Selkoe DJ. Folding proteins in fatal ways. Nature (2003) 426(6968):900-4. doi:10.1038/nature02264
39. Jiménez JS. Protein-DNA interaction at the origin of neurological diseases: a hypothesis. J Alzheimers Dis (2010) 22(2):375-91. doi:10.3233/JAD-2010-100189
40. Di Domizio J, Zhang R, Stagg LJ, Gagea M, Zhuo M, Ladbury JE, et al. Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid. J Biol Chem (2012) 287(1):736-47. doi:10.1074/jbc.M111.238477
41. Di Domizio J, Dorta-Estremera S, Gagea M, Ganguly D, Meller S, Li P, et al. Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity. Proc Natl Acad Sci U S A (2012) 109(36):14550-5. doi:10.1073/pnas.1206923109
42. Gallo PM, Rapsinski GJ, Wilson RP, Oppong GO, Sriram U, Goulian M, et al. Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity (2015) 42(6):1171-84. doi:10.1016/j.immuni.2015.06.002
43. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell (2007) 131(6):1059-71. doi:10.1016/j.cell.2007.10.014
44. Roan NR, Muller JA, Liu H, Chu S, Arnold F, Sturzel CM, et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe (2011) 10(6):541-50. doi:10.1016/j.chom.2011.10.010
45. Barnhart MM, Chapman MR. Curli biogenesis and function. Annu Rev Microbiol (2006) 60:131-47. doi:10.1146/annurev.micro.60.080805.142106
46. Claessen D, Rink R, de Jong W, Siebring J, de Vreugd P, Boersma FG, et al. A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils. Genes Dev (2003) 17(14):1714-26. doi:10.1101/gad.264303
47. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (2009) 325(5938):328-32. doi:10.1126/science.1173155
48. Badtke MP, Hammer ND, Chapman MR. Functional amyloids signal their arrival. Sci Signal (2009) 2(80):e43. doi:10.1126/scisignal.280pe43
49. Baccala R, Gonzalez-Quintial R, Schreiber RD, Lawson BR, Kono DH, Theofilopoulos AN. Anti-IFN-alpha/beta receptor antibody treatment ameliorates disease in lupus-predisposed mice. J Immunol (2012) 189(12):5976-84. doi:10.4049/jimmunol.1201477
50. Cao W. Pivotal functions of plasmacytoid dendritic cells in systemic autoimmune pathogenesis. J Clin Cell Immunol (2014) 5:e212. doi:10.4172/2155-9899.1000212
51. Shlomchik MJ, Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev (2012) 247(1):52-63. doi:10.1111/j.1600-065X.2012.01124.x
52. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Control systems and decision making for antibody production. Nat Immunol (2010) 11(8):681-8. doi:10.1038/ni.1900
53. MacLennan IC. Germinal centers. Annu Rev Immunol (1994) 12:117-39. doi:10.1146/annurev.iy.12.040194.001001
54. Kuchroo VK, Ohashi PS, Sartor RB, Vinuesa CG. Dysregulation of immune homeostasis in autoimmune diseases. Nat Med (2012) 18(1):42-7. doi:10.1038/nm.2621
55. Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol (2012) 8(6):337-47. doi:10.1038/nrrheum.2012.58
56. Soni C, Wong EB, Domeier PP, Khan TN, Satoh T, Akira S, et al. B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J Immunol (2014) 193(9):4400-14. doi:10.4049/jimmunol.1401720
57. Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, Wiedeman AE, et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med (2013) 210(12):2773-89. doi:10.1084/jem.20122798
58. Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity (2008) 28(1):18-28. doi:10.1016/j.immuni.2007.12.004
59. Mathian A, Gallegos M, Pascual V, Banchereau J, Koutouzov S. Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB/c mice. Eur J Immunol (2011) 41(3):863-72. doi:10.1002/eji.201040649
60. Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood (2011) 118(5):1305-15. doi:10.1182/blood-2011-01-331462
61. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol Res (2013) 55(1-3):210-6. doi:10.1007/s12026-012-8365-8
62. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood (2011) 118(5):1294-304. doi:10.1182/blood-2011-01-330530
63. Sawai CM, Sisirak V, Ghosh HS, Hou EZ, Ceribelli M, Staudt LM, et al. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J Exp Med (2013) 210(11):2151-9. doi:10.1084/jem.20130443
64. Buechler MB, Teal TH, Elkon KB, Hamerman JA. Cutting edge: type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling. J Immunol (2013) 190(3):886-91. doi:10.4049/jimmunol.1202739
65. van Blijswijk J, Schraml BU, Reis e Sousa C. Advantages and limitations of mouse models to deplete dendritic cells. Eur J Immunol (2013) 43(1):22-6. doi:10.1002/eji.201243022
66. Roberts LM, Ledvina HE, Tuladhar S, Rana D, Steele SP, Sempowski GD, et al. Depletion of alveolar macrophages in CD11c diphtheria toxin receptor mice produces an inflammatory response. Immun Inflamm Dis (2015) 3(2):71-81. doi:10.1002/iid3.51
67. Teichmann LL, Schenten D, Medzhitov R, Kashgarian M, Shlomchik MJ. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity (2013) 38(3):528-40. doi:10.1016/j.immuni.2012.11.017
68. Guiducci C, Gong M, Xu Z, Gill M, Chaussabel D, Meeker T, et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature (2010) 465(7300):937-41. doi:10.1038/nature09102
69. Zhan Y, Carrington EM, Ko HJ, Vikstrom IB, Oon S, Zhang JG, et al. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-alpha production. Arthritis Rheumatol (2015) 67(3):797-808. doi:10.1002/art.38966
70. Lichtman EI, Helfgott SM, Kriegel MA. Emerging therapies for systemic lupus erythematosus -focus on targeting interferon-alpha. Clin Immunol (2012) 143(3):210-21. doi:10.1016/j.clim.2012.03.005
71. Thanou A, Merrill JT. Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat Rev Rheumatol (2014) 10(1):23-34. doi:10.1038/nrrheum.2013.145